HEADER GLYCOSIDE HYDROLASE 11-MAY-01 1H4G TITLE OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT TITLE 2 INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B CONFORMATIONS TITLE 3 AT THE ACTIVE-CENTRE COMPND MOL_ID: 1; COMPND 2 MOLECULE: XYLANASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FAMILY 11 XYLANASE CATALYTIC DOMAIN; COMPND 5 EC: 3.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: 2-FLUORO-2-DEOXY-XYLOBIOSIDE COVALENTLY BOUND TO COMPND 8 NUCLEOPHILE GLU94 IN THE ACTIVE SITE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS AGARADHAERENS; SOURCE 3 ORGANISM_TAXID: 76935; SOURCE 4 EXPRESSION_SYSTEM: BACILLUS LICHENIFORMIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1402 KEYWDS GLYCOSIDE HYDROLASE, XYLANASE, OLIGOSACCHARIDE, TRANSITION-STATE, KEYWDS 2 INTERMEDIATE, MUTANT, BOAT CONFORMATION EXPDTA X-RAY DIFFRACTION AUTHOR E.SABINI,K.S.WILSON,S.DANIELSEN,M.SCHULEIN,G.J.DAVIES REVDAT 6 16-OCT-24 1H4G 1 HETSYN REVDAT 5 29-JUL-20 1H4G 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 11-MAR-20 1H4G 1 SEQRES REVDAT 3 24-JUL-19 1H4G 1 REMARK LINK REVDAT 2 24-FEB-09 1H4G 1 VERSN REVDAT 1 09-MAY-02 1H4G 0 JRNL AUTH E.SABINI,G.SULZENBACHER,M.DAUTER,Z.DAUTER,P.L.JORGENSEN, JRNL AUTH 2 M.SCHULEIN,C.DUPONT,G.J.DAVIES,K.S.WILSON JRNL TITL CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLYSIS: JRNL TITL 2 A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMEDIATE JRNL TITL 3 REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS JRNL TITL 4 FAMILY 11 XYLANASE. JRNL REF CHEM.BIOL. V. 6 483 1999 JRNL REFN ISSN 1074-5521 JRNL PMID 10381409 JRNL DOI 10.1016/S1074-5521(99)80066-0 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 171783 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3263 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 606 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.031 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.019 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.389 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H4G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1290008019. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8469 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 171783 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.70800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROP: 2UL PROTEIN (10 MG ML-1 IN 100MM REMARK 280 SODIUM ACETATE) PLUS 1UL RESERVOIR RESERVOIR: 100 MM MES PH 6.5, REMARK 280 30% AMMONIUM SULPHATE, PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.03050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.13500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.54900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.13500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.03050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.54900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 207 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2140 O HOH A 2238 3545 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 94 CD GLU A 94 OE2 0.067 REMARK 500 MET B 173 CG MET B 173 SD 0.538 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 81 CB - CG - CD2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 105 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 148 NE - CZ - NH1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 149 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 200 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 TYR B 81 CB - CG - CD2 ANGL. DEV. = -4.9 DEGREES REMARK 500 ASN B 103 CA - CB - CG ANGL. DEV. = 15.5 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 8.2 DEGREES REMARK 500 ARG B 148 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG B 152 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 PHE B 163 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 MET B 173 CA - CB - CG ANGL. DEV. = -22.6 DEGREES REMARK 500 MET B 173 CB - CG - SD ANGL. DEV. = -26.2 DEGREES REMARK 500 MET B 173 CG - SD - CE ANGL. DEV. = -31.3 DEGREES REMARK 500 TYR B 186 CB - CG - CD2 ANGL. DEV. = -4.2 DEGREES REMARK 500 TYR B 186 CB - CG - CD1 ANGL. DEV. = 5.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 197 100.90 -164.20 REMARK 500 ASN B 77 65.40 -111.96 REMARK 500 ASN B 197 98.89 -165.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 49 0.11 SIDE CHAIN REMARK 500 ARG B 49 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ASN B 77 10.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2007 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH B2002 DISTANCE = 6.05 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H4H RELATED DB: PDB REMARK 900 OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT REMARK 900 INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B REMARK 900 CONFORMATIONS AT THE ACTIVE-CENTRE DBREF 1H4G A 1 207 PDB 1H4G 1H4G 1 207 DBREF 1H4G B 1 207 PDB 1H4G 1H4G 1 207 SEQADV 1H4G PCA A 1 PDB 1H4G GLU 1 MODIFIED RESIDUE SEQADV 1H4G PCA B 1 PDB 1H4G GLU 1 MODIFIED RESIDUE SEQRES 1 A 207 PCA ILE VAL THR ASP ASN SER ILE GLY ASN HIS ASP GLY SEQRES 2 A 207 TYR ASP TYR GLU PHE TRP LYS ASP SER GLY GLY SER GLY SEQRES 3 A 207 THR MET ILE LEU ASN HIS GLY GLY THR PHE SER ALA GLN SEQRES 4 A 207 TRP ASN ASN VAL ASN ASN ILE LEU PHE ARG LYS GLY LYS SEQRES 5 A 207 LYS PHE ASN GLU THR GLN THR HIS GLN GLN VAL GLY ASN SEQRES 6 A 207 MET SER ILE ASN TYR GLY ALA ASN PHE GLN PRO ASN GLY SEQRES 7 A 207 ASN ALA TYR LEU CYS VAL TYR GLY TRP THR VAL ASP PRO SEQRES 8 A 207 LEU VAL GLU TYR TYR ILE VAL ASP SER TRP GLY ASN TRP SEQRES 9 A 207 ARG PRO PRO GLY ALA THR PRO LYS GLY THR ILE THR VAL SEQRES 10 A 207 ASP GLY GLY THR TYR ASP ILE TYR GLU THR LEU ARG VAL SEQRES 11 A 207 ASN GLN PRO SER ILE LYS GLY ILE ALA THR PHE LYS GLN SEQRES 12 A 207 TYR TRP SER VAL ARG ARG SER LYS ARG THR SER GLY THR SEQRES 13 A 207 ILE SER VAL SER ASN HIS PHE ARG ALA TRP GLU ASN LEU SEQRES 14 A 207 GLY MET ASN MET GLY LYS MET TYR GLU VAL ALA LEU THR SEQRES 15 A 207 VAL GLU GLY TYR GLN SER SER GLY SER ALA ASN VAL TYR SEQRES 16 A 207 SER ASN THR LEU ARG ILE ASN GLY ASN PRO LEU SER SEQRES 1 B 207 PCA ILE VAL THR ASP ASN SER ILE GLY ASN HIS ASP GLY SEQRES 2 B 207 TYR ASP TYR GLU PHE TRP LYS ASP SER GLY GLY SER GLY SEQRES 3 B 207 THR MET ILE LEU ASN HIS GLY GLY THR PHE SER ALA GLN SEQRES 4 B 207 TRP ASN ASN VAL ASN ASN ILE LEU PHE ARG LYS GLY LYS SEQRES 5 B 207 LYS PHE ASN GLU THR GLN THR HIS GLN GLN VAL GLY ASN SEQRES 6 B 207 MET SER ILE ASN TYR GLY ALA ASN PHE GLN PRO ASN GLY SEQRES 7 B 207 ASN ALA TYR LEU CYS VAL TYR GLY TRP THR VAL ASP PRO SEQRES 8 B 207 LEU VAL GLU TYR TYR ILE VAL ASP SER TRP GLY ASN TRP SEQRES 9 B 207 ARG PRO PRO GLY ALA THR PRO LYS GLY THR ILE THR VAL SEQRES 10 B 207 ASP GLY GLY THR TYR ASP ILE TYR GLU THR LEU ARG VAL SEQRES 11 B 207 ASN GLN PRO SER ILE LYS GLY ILE ALA THR PHE LYS GLN SEQRES 12 B 207 TYR TRP SER VAL ARG ARG SER LYS ARG THR SER GLY THR SEQRES 13 B 207 ILE SER VAL SER ASN HIS PHE ARG ALA TRP GLU ASN LEU SEQRES 14 B 207 GLY MET ASN MET GLY LYS MET TYR GLU VAL ALA LEU THR SEQRES 15 B 207 VAL GLU GLY TYR GLN SER SER GLY SER ALA ASN VAL TYR SEQRES 16 B 207 SER ASN THR LEU ARG ILE ASN GLY ASN PRO LEU SER MODRES 1H4G PCA A 1 GLU PYROGLUTAMIC ACID MODRES 1H4G PCA B 1 GLU PYROGLUTAMIC ACID HET PCA A 1 8 HET PCA B 1 8 HET X2F C 1 9 HET XYP C 2 9 HET X2F D 1 9 HET XYP D 2 9 HET SO4 A1208 5 HET SO4 B1209 5 HET SO4 B1210 5 HETNAM PCA PYROGLUTAMIC ACID HETNAM X2F 2-DEOXY-2-FLUORO-ALPHA-D-XYLOPYRANOSE HETNAM XYP BETA-D-XYLOPYRANOSE HETNAM SO4 SULFATE ION HETSYN X2F 2-DEOXY-2-FLUORO XYLOPYRANOSE; 2-DEOXY-2-FLUORO-ALPHA- HETSYN 2 X2F D-XYLOSE; 2-DEOXY-2-FLUORO-D-XYLOSE; 2-DEOXY-2-FLUORO- HETSYN 3 X2F XYLOSE HETSYN XYP BETA-D-XYLOSE; D-XYLOSE; XYLOSE FORMUL 1 PCA 2(C5 H7 N O3) FORMUL 3 X2F 2(C5 H9 F O4) FORMUL 3 XYP 2(C5 H10 O5) FORMUL 5 SO4 3(O4 S 2-) FORMUL 8 HOH *606(H2 O) HELIX 1 1 THR A 59 GLY A 64 1 6 HELIX 2 2 SER A 158 LEU A 169 1 12 HELIX 3 1 THR B 59 GLY B 64 1 6 HELIX 4 2 SER B 158 LEU B 169 1 12 SHEET 1 AA 5 ILE A 2 VAL A 3 0 SHEET 2 AA 5 SER A 25 LEU A 30 -1 O MET A 28 N VAL A 3 SHEET 3 AA 5 PHE A 36 ASN A 41 -1 O SER A 37 N ILE A 29 SHEET 4 AA 5 GLY A 190 VAL A 194 -1 O GLY A 190 N TRP A 40 SHEET 5 AA 5 GLN A 75 PRO A 76 -1 O GLN A 75 N SER A 191 SHEET 1 AB 4 GLY A 155 ILE A 157 0 SHEET 2 AB 4 MET A 66 TYR A 70 -1 O ILE A 68 N ILE A 157 SHEET 3 AB 4 THR A 198 ILE A 201 -1 O THR A 198 N ASN A 69 SHEET 4 AB 4 ASN A 204 PRO A 205 -1 O ASN A 204 N ILE A 201 SHEET 1 AC 9 SER A 7 HIS A 11 0 SHEET 2 AC 9 TYR A 14 LYS A 20 -1 O TYR A 14 N HIS A 11 SHEET 3 AC 9 ASN A 45 LYS A 53 -1 O LEU A 47 N TRP A 19 SHEET 4 AC 9 LYS A 175 TYR A 186 -1 O VAL A 179 N LYS A 52 SHEET 5 AC 9 ALA A 80 VAL A 89 -1 O TYR A 81 N GLU A 184 SHEET 6 AC 9 VAL A 93 TRP A 101 -1 O VAL A 93 N THR A 88 SHEET 7 AC 9 ALA A 139 ARG A 148 1 O LYS A 142 N GLU A 94 SHEET 8 AC 9 GLY A 120 GLN A 132 -1 O ASP A 123 N VAL A 147 SHEET 9 AC 9 GLY A 113 VAL A 117 -1 O GLY A 113 N ILE A 124 SHEET 1 BA 5 ILE B 2 VAL B 3 0 SHEET 2 BA 5 SER B 25 LEU B 30 -1 O MET B 28 N VAL B 3 SHEET 3 BA 5 PHE B 36 ASN B 41 -1 O SER B 37 N ILE B 29 SHEET 4 BA 5 GLY B 190 VAL B 194 -1 O GLY B 190 N TRP B 40 SHEET 5 BA 5 GLN B 75 PRO B 76 -1 O GLN B 75 N SER B 191 SHEET 1 BB 4 GLY B 155 ILE B 157 0 SHEET 2 BB 4 MET B 66 TYR B 70 -1 O ILE B 68 N ILE B 157 SHEET 3 BB 4 THR B 198 ILE B 201 -1 O THR B 198 N ASN B 69 SHEET 4 BB 4 ASN B 204 PRO B 205 -1 O ASN B 204 N ILE B 201 SHEET 1 BC 9 SER B 7 HIS B 11 0 SHEET 2 BC 9 TYR B 14 LYS B 20 -1 O TYR B 14 N HIS B 11 SHEET 3 BC 9 ASN B 45 LYS B 53 -1 O LEU B 47 N TRP B 19 SHEET 4 BC 9 LYS B 175 TYR B 186 -1 O VAL B 179 N LYS B 52 SHEET 5 BC 9 ALA B 80 VAL B 89 -1 O TYR B 81 N GLU B 184 SHEET 6 BC 9 VAL B 93 TRP B 101 -1 O VAL B 93 N THR B 88 SHEET 7 BC 9 ALA B 139 ARG B 148 1 O LYS B 142 N GLU B 94 SHEET 8 BC 9 GLY B 120 GLN B 132 -1 O ASP B 123 N VAL B 147 SHEET 9 BC 9 GLY B 113 VAL B 117 -1 O GLY B 113 N ILE B 124 LINK C PCA A 1 N ILE A 2 1555 1555 1.38 LINK OE2 GLU A 94 C1 X2F C 1 1555 1555 1.48 LINK C PCA B 1 N ILE B 2 1555 1555 1.43 LINK OE2 GLU B 94 C1 X2F D 1 1555 1555 1.51 LINK O4 X2F C 1 C1 XYP C 2 1555 1555 1.41 LINK O4 X2F D 1 C1 XYP D 2 1555 1555 1.41 CISPEP 1 ASP A 90 PRO A 91 0 6.44 CISPEP 2 PRO A 106 PRO A 107 0 3.41 CISPEP 3 ASP B 90 PRO B 91 0 7.93 CISPEP 4 PRO B 106 PRO B 107 0 -0.42 CRYST1 72.061 75.098 78.270 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013877 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013316 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012776 0.00000 HETATM 1 N PCA A 1 12.777 12.471 31.265 1.00 13.38 N ANISOU 1 N PCA A 1 1662 2127 1293 258 -34 75 N HETATM 2 CA PCA A 1 12.179 12.348 29.948 1.00 14.10 C ANISOU 2 CA PCA A 1 1595 2335 1427 225 77 -53 C HETATM 3 CB PCA A 1 12.832 11.142 29.268 1.00 14.49 C ANISOU 3 CB PCA A 1 1682 2521 1302 474 -162 -240 C HETATM 4 CG PCA A 1 13.359 10.328 30.463 1.00 15.94 C ANISOU 4 CG PCA A 1 1982 2455 1620 410 -279 -139 C HETATM 5 CD PCA A 1 13.442 11.346 31.600 1.00 14.40 C ANISOU 5 CD PCA A 1 1743 2284 1446 432 -30 -38 C HETATM 6 OE PCA A 1 14.052 11.201 32.687 1.00 14.60 O ANISOU 6 OE PCA A 1 1774 2329 1443 504 -199 -266 O HETATM 7 C PCA A 1 10.663 12.168 30.019 1.00 12.95 C ANISOU 7 C PCA A 1 1576 2064 1282 306 25 62 C HETATM 8 O PCA A 1 9.962 11.846 29.023 1.00 13.72 O ANISOU 8 O PCA A 1 1674 2301 1238 251 -84 68 O